Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.nejm.org › doi › fullEffect of Early Treatment with Ivermectin among Patients with...

   www.nejm.org › doi › full

   30 mar 2022 · The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the...

   • Original Article Two Phase 3 Trials of Baricitinib for Alopecia Areata B. King and Others

     We enrolled 654 patients in the BRAVE-AA1 trial and 546 in...

   • Images in Clinical Medicine Primary Cutaneous Blastomycosis A. Alhatem and K.C. Smith

     A 53-year-old landscaper presented with a 4-month history of...

   • Perspective Real-World Evidence — Where Are We Now J. Concato and J. Corrigan-Curay

     Interview with Kushal Kadakia on the 21st Century Cures Act,...

   • Clinical Practice Nonspecific Low Back Pain A. Chiarotto and B.W. Koes

     Nonspecific low back pain is diagnosed by ruling out other...

   • Editorial Baricitinib in Alopecia Areata A. Messenger and M. Harries

     Scalp hair regrowth is associated with improvements in...

   • Clinical Problem-Solving Looking Back L. Glick and Others

     On examination, the temperature was 36.1°C, the blood...

   • Correspondence Dec 15, 2022 Ivermectin Treatment for Covid-19

     Given the wide availability and low cost of ivermectin and...

   • Editorial Audio Interview

     In this audio interview conducted on May 2, 2022, the...

2. pubmed.ncbi.nlm.nih.gov › 33278625A five-day course of ivermectin for the treatment of COVID-19 may...

   pubmed.ncbi.nlm.nih.gov › 33278625

   A 5-day course of ivermectin was found to be safe and effective in treating adult patients with mild COVID-19. Larger trials will be needed to confirm these preliminary findings. Keywords: Bangladesh; COVID-19; Doxycycline; Ivermectin; SARS-CoV-2.

3. www.nejm.org › doi › fullIvermectin Treatment for Covid-19 | NEJM - New England Journal of...

   www.nejm.org › doi › full

   14 gru 2022 · Given the wide availability and low cost of ivermectin and that the dosage used in the trial appeared to be safe, such treatment effects could be an important benefit for high-risk patients who...

4. www.thelancet.com › journals › eclinmAntiviral effect of high-dose ivermectin in adults with COVID-19:...

   www.thelancet.com › journals › eclinm

   17 cze 2021 · A concentration dependent antiviral effect of ivermectin in COVID-19 was identified, with significant reductions in SARS-CoV-2 viral load in respiratory secretions among patients achieving high systemic ivermectin concentration compared to untreated controls.

5. pmc.ncbi.nlm.nih.gov › articles › PMC7709596A five-day course of ivermectin for the treatment of COVID-19 may...

   pmc.ncbi.nlm.nih.gov › articles › PMC7709596

   This pilot study was performed to evaluate the rapidity of viral clearance and safety of a 5-day course of ivermectin or a single-dose of ivermectin + a 5-day course of doxycycline in the treatment of mild COVID-19 in adults.

6. www.sciencedirect.com › science › articleEfficacy and safety of ivermectin for treatment of...

   www.sciencedirect.com › science › article

   1 sie 2024 · Five databases were searched until October 17, 2023, for randomized controlled trials (RCTs) in adult patients with COVID-19 treated with ivermectin against standard of care (SoC), placebo, or active drug. Primary outcomes were hospitalization, all-cause mortality, and adverse events (AEs).

7. bmjopen.bmj.com › content › 11Effectiveness and safety of ivermectin in the treatment of...

   bmjopen.bmj.com › content › 11

   • Zapisane w pamięci cache

   Therefore, this protocol describes a systematic review for assessing the efficacy and safety of ivermectin in the prophylaxis and treatment of COVID-19 based on updated data, including those from RCTs.